Long term use of oral hormone therapy is associated with a small increased risk of Alzheimer's disease in postmenopausal women.
Mouse study identifies specific neurons and a signaling pathway to regions of the hindbrain that mediate sexual reproductive activity and physical activity that appear to influence activity behaviors during ovulation. The findings may provide valuable insights into how estrogen loss during menopause disrupts this activity.
Researchers identify a link between waist-to-height ratio and risk of developing anxiety in menopausal women.
A new study reports the effects of hormone therapy on a woman's memory and mental skills is negligible, regardless of how soon it is given to postmenopaual women.
A new study examines the connection between hot flashes in menopause and brain health.
A new study confirms the link between menstruation and worsening of psychosis symptoms in women with mental health disorders. Researchers found psychiatric admissions for women were one-and-a-half times higher during the time of menstruation.
A new study suggests that blood may hold clues to whether post-menopausal women may have an increased risk for brain damage that can lead to memory problems and an increased risk of stroke.
Researchers are testing a new drug, which can be used as an alternative to estrogen therapy for menopausal women. Early data shows the drug significantly reduced the total number of weekly hot flashes in women by 73% and was well tolerated by those who took it.
A new study reveals women experience a decline in sexual function 20 months before and one year following their last menstrual cycle.
Women who experience menopause before the age of 40 are significantly more likely to develop dementia later in life than women who began menopause aged 50 or older.
By inducing hot flashes, most commonly associated with menopause, in both male and female mice, researchers discover Kiss1 neurons initiate a fast boost in skin temperature followed by a drop in core body temperature.
Hormone replacement therapy (HRT) use was associated with better cognition, memory, and larger brain volume in women who carry the Alzheimer's associated APOE4 genetic variant.
